** Shares of bio-technology company Allergy Therapeutics
AGY.L plunge 73.6% to record low of 1.65p
** Co's half-year gross profit falls 28% due to high costs
and short-term pause in production in Oct
** Logs HY gross profit of 25.8 mln pounds ($33 mln) vs 35.9
mln pounds a year ago
** Says trading suspension lifted; trading was suspended in
Jan pending publication of audited accounts
** Adds additional funding required from September for
trading, working capital and R&D programmes
** If losses hold, stock set to post record intraday pct
decline
** Stock was down 81% in 2022
($1 = 0.7811 pounds)
(Reporting by Hani Kollathodi in Bengaluru)
((Hani.Kollathodi@thomsonreuters.com;))